Compounds > 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone
Page last updated: 2024-08-23

4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone and Cancer, Second Primary

4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone has been researched along with Cancer, Second Primary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hisamoto, A; Hosokawa, S; Kiura, K; Kondo, E; Mimoto, J; Okada, T; Tabata, M; Takigawa, N; Tanimoto, M1

Other Studies

1 other study(ies) available for 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone and Cancer, Second Primary

ArticleYear
Point mutation of K-ras gene in cisplatin-induced lung tumours in A/J mice.
    Lung cancer (Amsterdam, Netherlands), 2007, Volume: 58, Issue:1

    Topics: Adenocarcinoma; Animals; Benzo(a)pyrene; Carcinogens; Carcinoma, Non-Small-Cell Lung; Cisplatin; Codon; Female; Genes, ras; Lung Neoplasms; Mice; Neoplasms, Experimental; Neoplasms, Second Primary; Nitrosamines; Point Mutation

2007